Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 9, 1999New England Journal of Medicine

Miltefosine — The Long-Awaited Therapy for Visceral Leishmaniasis?

View Full Paper
Ask AI
Bookmark
Share

Authors

BHBarbara L. HerwaldtCenters for Disease Control and Prevention

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Barbara L. Herwaldt (1999) studied this question.

synapsesocial.com/papers/6aa56eae4c67234624eeb7dehttps://doi.org/10.1056/nejm199912093412411
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epidemic Visceral Leishmaniasis in Southern Sudan: Treatment of Severely Debilitated Patients under Wartime Conditions and with Limited Resources1996 · 133 citations
  2. 2Trial of oral miltefosine for visceral leishmaniasis1998 · 246 citations
  3. 3Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice1992 · 198 citations
  4. 4Oral treatment of visceral leishmaniasis with miltefosine1999 · 92 citations
  5. 5The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei1996 · 182 citations